News Sentiment

ICU sentiment intelligence

SeaStar Medical Holding Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 61 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.00 Week of 17 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-19.2% over one week, +28.2% over four weeks, trend active, and below fair value.

Latest direct headline Positive

KeyBanc raises ICU Medical stock price target on pump growth

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -19.2% Price reacting lower
Trend fit Trend active 28.2% over four weeks
Fair value -92.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 46
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
Market source 15
TradingKey 9
Investing.com 4
simplywall.st 4
GlobeNewswire 3
MarketBeat 2
Investing.com Canada 1

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 22
Macro sensitivity 2
Balance sheet 2
Deals and strategy 2
Analyst action 1
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 61
Investing.com Direct company coverage

SeaStar Medical sponsors pediatric kidney injury summit

SeaStar Medical (NASDAQ: ICU) is sponsoring the KidneyBee Summit 2026 and an educational webinar to address pediatric acute kidney injury. The company's QUELIMMUNE therapy, approved for critically ill children with AKI and sepsis, has shown high survival rates in clinical trials.

Tone
Positive 74/100
Event
Macro sensitivity
Published
14 Jul 2026 13:10
Source
Investing.com
Stock Titan Direct company coverage

SeaStar Medical: More Than 50% of Children With Severe Kidney Injury Die

SeaStar Medical (Nasdaq: ICU) announced its sponsorship of key educational initiatives to improve critical care for pediatric patients suffering from acute kidney injury (AKI), a condition that tragically leads to the death of over 50% of affected children in ICUs. The company is

Tone
Positive 65/100
Event
Market update
Published
14 Jul 2026 12:11
Source
Stock Titan
Stock Titan Direct company coverage

4,000-share RSU grant to SeaStar Medical (ICU) director disclosed

SeaStar Medical Holding Corp. (ICU) director Bernadette N. Vincent was granted 4,000 restricted stock units (RSUs) on July 1, 2026, which will vest in full on July 1, 2027. The grant was awarded at $0.00 per share, indicating a compensation grant rather than a purchase. This tran

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 02:10
Source
Stock Titan
Stock Titan Direct company coverage

SeaStar Medical (NASDAQ: ICU) director receives 4,000 restricted stock units

SeaStar Medical (NASDAQ: ICU) director Jennifer A. Baird was granted 4,000 restricted stock units (RSUs) which will fully vest on July 1, 2027. Following this award, her direct holdings in the company's common stock now total 10,620 shares. This transaction was reported in a Form

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 21:11
Source
Stock Titan
Stock Titan Direct company coverage

SeaStar Medical (ICU) director granted 4,000 restricted stock units

SeaStar Medical (ICU) director Kenneth Van Heel was granted 4,000 Restricted Stock Units (RSUs) on July 1, 2026. These RSUs will fully vest on July 1, 2027, provided he remains eligible. Following this grant, Van Heel directly holds 11,940 shares of the company's common stock.

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 21:11
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 4 SeaStar Medical Holding Corp For: 2 July By Investing.com

This article from Investing.com reports on a Form 4 filing for SeaStar Medical Holding Corp for the date of July 2nd. The content appears to be a brief announcement with financial market data and popular news headlines, but does not contain detailed information about the Form 4 i

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 21:11
Source
Investing.com Canada
Stock Titan Direct company coverage

SeaStar Medical (ICU) CEO receives 10,288 restricted stock units in equity grant

SeaStar Medical Holding Corp's CEO, Eric Schlorff, has been granted 10,288 restricted stock units (RSUs) as an equity award, not an open-market purchase. These RSUs, valued at $0.00 per share, will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 21:11
Source
Stock Titan
Stock Titan Direct company coverage

SeaStar Medical (ICU) director awarded 4,000 RSUs, holdings now 16,200 shares

SeaStar Medical director John Neuman was awarded 4,000 Restricted Stock Units (RSUs) as compensation, not through an open-market purchase. These RSUs will fully vest on July 1, 2027. Following this grant, Neuman's total holdings in SeaStar Medical common stock now stand at 16,200

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 21:11
Source
Stock Titan
Stock Titan Direct company coverage

SeaStar Medical (ICU) adopts 2026 retention bonus program for top executives

SeaStar Medical Holding Corporation has approved a 2026 Retention Bonus Program for executives Eric Schlorff ($200,000) and Kevin Chung ($140,000). The bonuses will be paid in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, subject to continued empl

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

SeaStar Medical (ICU) grants CMO 7,202 restricted stock units

SeaStar Medical Holding Corp. has granted its Chief Medical Officer, Kevin Chung, 7,202 restricted stock units (RSUs) as part of his compensation, at no cash cost to him. These RSUs will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, bringi

Tone
Neutral 50/100
Event
Balance sheet
Published
30 Jun 2026 08:11
Source
Stock Titan
Market source Direct company coverage

SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury

SeaStar Medical (Nasdaq: ICU) announced the acquisition of dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services (CMS) for its Selective Cytopheretic Device (SCD) therapy. These codes will enable standardized inpatient hospital billing and reporting for the

Tone
Positive 73/100
Event
Deals and strategy
Published
23 Jun 2026 22:11
Source
Market source
Stock Titan Direct company coverage

SeaStar Medical (NASDAQ: ICU) amends Mr. Green separation deal

SeaStar Medical Holding Corporation (NASDAQ: ICU) filed an amended 8-K report clarifying a new separation and release agreement with Mr. Green, entered into on June 10, 2026. This amendment updates terms related to his disputed not-for-cause termination, with SeaStar Medical agre

Tone
Neutral 50/100
Event
Deals and strategy
Published
23 Jun 2026 20:42
Source
Stock Titan
Stock Titan Direct company coverage

Hospitals get new billing codes for SeaStar Medical’s kidney therapy

SeaStar Medical (Nasdaq: ICU) announced that its Selective Cytopheretic Device (SCD) therapy for acute kidney injury requiring renal replacement therapy has received dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services (CMS). These new codes, effective Oct

Tone
Positive 75/100
Event
Market update
Published
23 Jun 2026 12:42
Source
Stock Titan
TradingKey Direct company coverage

SeaStar Medical Holding Corp (ICUCW) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of SeaStar Medical Holding Corp (ICUCW), detailing its current stock price, market capitalization, and various technical indicators. The analysis shows a prevailing "Sell" signal based on both technical indicators and moving averages, wi

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 12:09
Source
TradingKey
Market source Direct company coverage

SeaStar Medical to Present at Upcoming Investor Summit Conference

SeaStar Medical Holding Corporation announced that CEO Eric Schlorff will present at the Virtual Investor Summit Conference on June 24th at 10:30 am Eastern Time. The company, focused on treatments for critically ill patients, recently received FDA approval for QUELIMMUNE® (SCD-P

Tone
Positive 71/100
Event
Regulatory and legal
Published
22 Jun 2026 12:39
Source
Market source
Stock Titan Direct company coverage

SeaStar Medical CEO to present at virtual investor summit June 24

SeaStar Medical (Nasdaq: ICU) announced that CEO Eric Schlorff will present at the Virtual Investor Summit Conference on June 24, 2026, at 10:30 a.m. Eastern Time. The company, a commercial-stage healthcare firm, focuses on treatments for critically ill patients with organ failur

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 12:39
Source
Stock Titan
TradingKey Direct company coverage

SeaStar Medical Holding Corp (ICUCW) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for SeaStar Medical Holding Corp (ICUCW), focusing on its PE, PB, P/S, and P/CF ratios. The analysis indicates that relevant data for these metrics have not yet been disclosed by the company. TradingKey provides this financial informatio

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 11:10
Source
TradingKey
TradingKey Direct company coverage

SeaStar Medical Holding Corp (ICUCW) Institutional Confidence

This article provides details on the institutional confidence in SeaStar Medical Holding Corp (ICUCW), including its stock price, market cap, and a breakdown of institutional shareholdings. The data shows key institutional investors and their changes in shares held, with some fir

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 11:10
Source
TradingKey
TradingKey Direct company coverage

SeaStar Medical Holding Corp

This article provides an overview of SeaStar Medical Holding Corp (ICU), including its current stock price and key financial metrics like market capitalization. It indicates that detailed revenue breakdown by business segment and region has not yet been disclosed by the company.

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 08:11
Source
TradingKey
TradingKey Direct company coverage

SeaStar Medical Holding Corp (ICUCW) Financial Health: Profitability & Balance Sheet Analysis

This article from TradingKey provides an overview of SeaStar Medical Holding Corp's (ICUCW) financial health, specifically focusing on profitability and balance sheet analysis. It notes that relevant financial data for key metrics such as cash and equivalents, total assets, liabi

Tone
Neutral 50/100
Event
Balance sheet
Published
19 Jun 2026 08:10
Source
TradingKey
Investing.com Direct company coverage

SeaStar Medical shareholders approve equity plan expansion and board election

SeaStar Medical shareholders have approved all proposals at their annual meeting, including the election of John Neuman as a Class I director and an amendment to expand the company's 2022 Omnibus Incentive Plan. They also ratified the appointment of WithumSmith+Brown, PC as their

Tone
Positive 66/100
Event
Market update
Published
18 Jun 2026 21:39
Source
Investing.com